Nucleic Acid Based Gene Therapy Market Report 2026
Nucleic Acid Based Gene Therapy Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Nucleic Acid Based Gene Therapy Market Report 2026

Global Outlook – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Nucleic Acid Based Gene Therapy Market Overview

• Nucleic Acid Based Gene Therapy market size has reached to $0.88 billion in 2025

• Expected to grow to $1.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%

• Growth Driver: Rising Financial Support by Governments and Companies Accelerating Gene Therapy Development

• Market Trend: Personalized Autologous Stem Cell Therapies Driving Growth in Rare Disease Treatment

North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Nucleic Acid Based Gene Therapy Market?

Nucleic acid-based gene therapy is a medical treatment approach that uses nucleic acids (such as DNA or RNA) to modify or manipulate genes within a patient's cells to treat or prevent diseases. This therapy aims to address the root cause of a disease at the genetic level by directly intervening in the genetic material that leads to the malfunctioning of cells.

The main technologies in nucleic acid-based gene therapy are anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogues, ribozymes, aptamers, and others. The nucleoside analogues are a significant class of antiviral agents that are generally utilized in the therapy of human immunodeficiency virus (HIV) infection, hepatitis B virus (HBV), hepatitis C virus (HCV), and cytomegalovirus (CMV). The various applications include oncology, muscular dystrophy, muscular disorders, and rare diseases that are used by end-users such as hospitals and clinics and academic and research institutes.

Nucleic Acid Based Gene Therapy market report bar graph

What Is The Nucleic Acid Based Gene Therapy Market Size and Share 2026?

The nucleic acid based gene therapy market size has grown rapidly in recent years. It will grow from $0.88 billion in 2025 to $0.97 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to advancements in molecular biology research, increased understanding of genetic disease mechanisms, expansion of clinical trials for gene therapies, rising investment in biotechnology research, early regulatory approvals for nucleic acid therapies.

What Is The Nucleic Acid Based Gene Therapy Market Growth Forecast?

The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing adoption of crispr-based treatments, rising demand for rare disease therapies, expansion of gene therapy manufacturing facilities, growing focus on personalized oncology treatments, increasing public and private funding for genetic medicine. Major trends in the forecast period include increasing adoption of rna-based therapeutics, rising use of viral and non-viral gene delivery systems, growing focus on targeted gene editing technologies, expansion of personalized genetic therapies, enhanced emphasis on precision medicine applications.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Nucleic Acid Based Gene Therapy Market Segmentation

1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies

2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases

3) By End User: Hospitals And Clinics, Academic And Research Institutes

Subsegments:

1) By Anti-Sense And Anti-Gene: Oligonucleotide Therapeutics, Peptide Nucleic Acids (PNA), Morpholino Oligomers (MO)

2) By Short Inhibitory Sequences (siRNA): Synthetic siRNA, Encapsulation/Delivery Systems for siRNA, Target-specific siRNA Therapies

3) By Gene Transfer Therapy: Viral Vectors (Adenovirus, Lentivirus, Retrovirus, AAV), Non-Viral Vectors (Liposomes, Electroporation, Gene Gun)

4) By Nucleoside Analogs: Purine Analogs, Pyrimidine Analogs

5) By Ribozymes: Trans-Splicing Ribozymes, Hammerhead Ribozymes

6) By Aptamers: RNA Aptamers, DNA Aptamers, Small Molecule Binding Aptamers

7) By Other Technologies: CRISPR-based Gene Editing, Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALENs)

What Is The Driver Of The Nucleic Acid Based Gene Therapy Market?

The rising financial support by governments and companies is expected to propel the growth of the nucleic acid based gene therapy market going forward. Financial support refers to monetary investments, grants, or subsidies provided by public or private institutions to advance research, development, and commercialization of therapies. The rising financial support is due to increasing global prioritization of treatments for rare and genetic diseases that currently lack effective cures. Government funding in nucleic-acid–based gene therapy accelerates progress by supplying the essential resources for research, clinical trials, and infrastructure that directly drive innovation and translation into effective treatments. For instance, in July 2023, according to the U.S. National Institutes of Health, a U.S.-based federal health research agency, over $140 million was awarded to accelerate genome editing approaches, including CRISPR and other nucleic acid technologies, for rare neurological and blood disorders, marking a significant increase compared to prior annual funding of $92 million in 2022. Therefore, the rising financial support by governments and companies is driving the growth of the nucleic acid based gene therapy industry.

Key Players In The Global Nucleic Acid Based Gene Therapy Market

Major companies operating in the nucleic acid based gene therapy market are Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc.

Global Nucleic Acid Based Gene Therapy Market Trends and Insights

Major companies operating in the nucleic acidbased gene therapy market are focusing on personalized, autologous stem-cell therapies, such as genetically modified hematopoietic stem-cell infusions, to treat rare inherited diseases. Autologous therapies refer to treatments in which a patient’s own stem cells are removed, genetically corrected and re-infused to restore the missing biochemical function. For instance, in March 2024, Orchard Therapeutics, a US-based company that offers pharmaceuticals announced Lenmeldy (atidarsagene autotemcel) approved by the U.S. Food and Drug Administration for children with metachromatic leukodystrophy (MLD). Lenmeldy uses the patient’s own hematopoietic stem cells that have been genetically modified to express a functional ARSA gene, enabling enzyme restoration in the nervous system. This regulatory success underscores how companies can commercialize complex, autologous gene therapies despite high manufacturing costs.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market?

In March 2023, Moderna, Inc., a US-based biotechnology company partnered with Generation Bio. With this partnership, Moderna Inc. aims to develop novel nucleic acid therapeutics, including those capable of reaching immune cells, to accelerate their respective pipelines of non-viral genetic medicines and fund all research and development activities associated with this collaboration, including a pre-payment for research efforts. Generation Bio is a US-based biotechnology company that provides nucleic acid based gene therapy.

Regional Outlook

North America was the largest region in the nucleic acid-based gene therapy market in 2025. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Nucleic Acid Based Gene Therapy Market?

The nucleic acid based gene therapy market consists of sales of nucleic acid based gene therapy technologies such as anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nucleic Acid Based Gene Therapy Market Report 2026?

The nucleic acid based gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid based gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Nucleic Acid Based Gene Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.97 billion
Revenue Forecast In 2035 $1.44 billion
Growth Rate CAGR of 10.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Technology, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nucleic Acid Based Gene Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nucleic Acid Based Gene Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nucleic Acid Based Gene Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nucleic Acid Based Gene Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Rna-Based Therapeutics

4.2.2 Rising Use Of Viral And Non-Viral Gene Delivery Systems

4.2.3 Growing Focus On Targeted Gene Editing Technologies

4.2.4 Expansion Of Personalized Genetic Therapies

4.2.5 Enhanced Emphasis On Precision Medicine Applications

5. Nucleic Acid Based Gene Therapy Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Academic And Research Institutes

5.3 Biotechnology Companies

5.4 Contract Research Organizations

5.5 Specialized Gene Therapy Centers

6. Nucleic Acid Based Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nucleic Acid Based Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nucleic Acid Based Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nucleic Acid Based Gene Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nucleic Acid Based Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nucleic Acid Based Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nucleic Acid Based Gene Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nucleic Acid Based Gene Therapy Market Segmentation

9.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies

9.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases

9.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Academic And Research Institutes

9.4. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Anti-Sense And Anti-Gene, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oligonucleotide Therapeutics, Peptide Nucleic Acids (PNA), Morpholino Oligomers (MO)

9.5. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Short Inhibitory Sequences (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Synthetic siRNA, Encapsulation/Delivery Systems for siRNA, Target-specific siRNA Therapies

9.6. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Gene Transfer Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vectors (Adenovirus, Lentivirus, Retrovirus, AAV), Non-Viral Vectors (Liposomes, Electroporation, Gene Gun)

9.7. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Nucleoside Analogs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Purine Analogs, Pyrimidine Analogs

9.8. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Ribozymes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Trans-Splicing Ribozymes, Hammerhead Ribozymes

9.9. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

RNA Aptamers, DNA Aptamers, Small Molecule Binding Aptamers

9.10. Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CRISPR-based Gene Editing, Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALENs)

10. Nucleic Acid Based Gene Therapy Market Regional And Country Analysis

10.1. Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nucleic Acid Based Gene Therapy Market

11.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nucleic Acid Based Gene Therapy Market

12.1. China Nucleic Acid Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nucleic Acid Based Gene Therapy Market

13.1. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nucleic Acid Based Gene Therapy Market

14.1. Japan Nucleic Acid Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nucleic Acid Based Gene Therapy Market

15.1. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nucleic Acid Based Gene Therapy Market

16.1. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nucleic Acid Based Gene Therapy Market

17.1. South Korea Nucleic Acid Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Bangladesh Nucleic Acid Based Gene Therapy Market

18.1. Bangladesh Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Thailand Nucleic Acid Based Gene Therapy Market

19.1. Thailand Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Vietnam Nucleic Acid Based Gene Therapy Market

20.1. Vietnam Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Malaysia Nucleic Acid Based Gene Therapy Market

21.1. Malaysia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Singapore Nucleic Acid Based Gene Therapy Market

22.1. Singapore Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Philippines Nucleic Acid Based Gene Therapy Market

23.1. Philippines Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Hong Kong Nucleic Acid Based Gene Therapy Market

24.1. Hong Kong Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. New Zealand Nucleic Acid Based Gene Therapy Market

25.1. New Zealand Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Taiwan Nucleic Acid Based Gene Therapy Market

26.1. Taiwan Nucleic Acid Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Taiwan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. South East Asia Nucleic Acid Based Gene Therapy Market

27.1. South East Asia Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. South East Asia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Western Europe Nucleic Acid Based Gene Therapy Market

28.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. UK Nucleic Acid Based Gene Therapy Market

29.1. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Germany Nucleic Acid Based Gene Therapy Market

30.1. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. France Nucleic Acid Based Gene Therapy Market

31.1. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Italy Nucleic Acid Based Gene Therapy Market

32.1. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Spain Nucleic Acid Based Gene Therapy Market

33.1. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Austria Nucleic Acid Based Gene Therapy Market

34.1. Austria Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Belgium Nucleic Acid Based Gene Therapy Market

35.1. Belgium Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Denmark Nucleic Acid Based Gene Therapy Market

36.1. Denmark Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

37. Finland Nucleic Acid Based Gene Therapy Market

37.1. Finland Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

38. Ireland Nucleic Acid Based Gene Therapy Market

38.1. Ireland Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

39. Netherlands Nucleic Acid Based Gene Therapy Market

39.1. Netherlands Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40. Norway Nucleic Acid Based Gene Therapy Market

40.1. Norway Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

41. Portugal Nucleic Acid Based Gene Therapy Market

41.1. Portugal Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Sweden Nucleic Acid Based Gene Therapy Market

42.1. Sweden Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Switzerland Nucleic Acid Based Gene Therapy Market

42.1. Switzerland Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

43. Eastern Europe Nucleic Acid Based Gene Therapy Market

43.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

43.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

44. Russia Nucleic Acid Based Gene Therapy Market

44.1. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

45. Czech Republic Nucleic Acid Based Gene Therapy Market

45.1. Czech Republic Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

46. Poland Nucleic Acid Based Gene Therapy Market

46.1. Poland Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

47. Romania Nucleic Acid Based Gene Therapy Market

47.1. Romania Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

48. Ukraine Nucleic Acid Based Gene Therapy Market

48.1. Ukraine Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

49. North America Nucleic Acid Based Gene Therapy Market

49.1. North America Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

49.2. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50. USA Nucleic Acid Based Gene Therapy Market

50.1. USA Nucleic Acid Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

50.2. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

51. Canada Nucleic Acid Based Gene Therapy Market

51.1. Canada Nucleic Acid Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

51.2. Canada Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

52. Mexico Nucleic Acid Based Gene Therapy Market

52.1. Mexico Nucleic Acid Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

52.2. Mexico Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

53. South America Nucleic Acid Based Gene Therapy Market

53.1. South America Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

53.2. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

54. Brazil Nucleic Acid Based Gene Therapy Market

54.1. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

55. Chile Nucleic Acid Based Gene Therapy Market

55.1. Chile Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

56. Argentina Nucleic Acid Based Gene Therapy Market

56.1. Argentina Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

57. Colombia Nucleic Acid Based Gene Therapy Market

57.1. Colombia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

58. Peru Nucleic Acid Based Gene Therapy Market

58.1. Peru Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

59. Middle East Nucleic Acid Based Gene Therapy Market

59.1. Middle East Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

59.2. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

60. Saudi Arabia Nucleic Acid Based Gene Therapy Market

60.1. Saudi Arabia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

61. Israel Nucleic Acid Based Gene Therapy Market

61.1. Israel Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

62. Iran Nucleic Acid Based Gene Therapy Market

62.1. Iran Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

63. Turkey Nucleic Acid Based Gene Therapy Market

63.1. Turkey Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

64. United Arab Emirates Nucleic Acid Based Gene Therapy Market

64.1. United Arab Emirates Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

65. Africa Nucleic Acid Based Gene Therapy Market

65.1. Africa Nucleic Acid Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

65.2. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

66. Egypt Nucleic Acid Based Gene Therapy Market

66.1. Egypt Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

67. Nigeria Nucleic Acid Based Gene Therapy Market

67.1. Nigeria Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

68. South Africa Nucleic Acid Based Gene Therapy Market

68.1. South Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

69. Nucleic Acid Based Gene Therapy Market Regulatory and Investment Landscape

70. Nucleic Acid Based Gene Therapy Market Competitive Landscape And Company Profiles

70.1. Nucleic Acid Based Gene Therapy Market Competitive Landscape And Market Share 2024

70.1.1. Top 10 Companies (Ranked by revenue/share)

70.2. Nucleic Acid Based Gene Therapy Market - Company Scoring Matrix

70.2.1. Market Revenues

70.2.2. Product Innovation Score

70.2.3. Brand Recognition

70.3. Nucleic Acid Based Gene Therapy Market Company Profiles

70.3.1. Celsion Corporation Overview, Products and Services, Strategy and Financial Analysis

70.3.2. Wave Life Sciences Overview, Products and Services, Strategy and Financial Analysis

70.3.3. Imugene Ltd. Overview, Products and Services, Strategy and Financial Analysis

70.3.4. Caperna LLC Overview, Products and Services, Strategy and Financial Analysis

70.3.5. Phylogica Limited Overview, Products and Services, Strategy and Financial Analysis

71. Nucleic Acid Based Gene Therapy Market Other Major And Innovative Companies

Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc.

72. Global Nucleic Acid Based Gene Therapy Market Competitive Benchmarking And Dashboard

73. Key Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market

74. Nucleic Acid Based Gene Therapy Market High Potential Countries, Segments and Strategies

74.1 Nucleic Acid Based Gene Therapy Market In 2030 - Countries Offering Most New Opportunities

74.2 Nucleic Acid Based Gene Therapy Market In 2030 - Segments Offering Most New Opportunities

74.3 Nucleic Acid Based Gene Therapy Market In 2030 - Growth Strategies

74.3.1 Market Trend Based Strategies

74.3.2 Competitor Strategies

75. Appendix

75.1. Abbreviations

75.2. Currencies

75.3. Historic And Forecast Inflation Rates

75.4. Research Inquiries

75.5. The Business Research Company

75.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Nucleic Acid Based Gene Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Nucleic Acid Based Gene Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Nucleic Acid Based Gene Therapy Market, Supply Chain Analysis
  • Table 4: Global Nucleic Acid Based Gene Therapy Market, Major Raw Material Providers
  • Table 5: Global Nucleic Acid Based Gene Therapy Market, Major Resource Providers
  • Table 6: Global Nucleic Acid Based Gene Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Nucleic Acid Based Gene Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global Nucleic Acid Based Gene Therapy Market, Key Technologies & Future Trends
  • Table 9: Global Nucleic Acid Based Gene Therapy Market, Major Trends
  • Table 10: Global Nucleic Acid Based Gene Therapy Market, Major End Users
  • Table 11: Global Nucleic Acid Based Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Nucleic Acid Based Gene Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Nucleic Acid Based Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Nucleic Acid Based Gene Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Anti-Sense And Anti-Gene, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Short Inhibitory Sequences (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Gene Transfer Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Nucleoside Analogs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Ribozymes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Bangladesh, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Bangladesh, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Bangladesh, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Thailand, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Thailand, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Thailand, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Vietnam, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Vietnam, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Vietnam, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Malaysia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Malaysia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Malaysia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Singapore, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Singapore, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Singapore, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Philippines, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Philippines, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Philippines, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Hong Kong, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Hong Kong, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Hong Kong, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: New Zealand, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: New Zealand, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: New Zealand, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Taiwan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Taiwan, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Taiwan, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: South East Asia , Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: South East Asia , Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: South East Asia , Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: France, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Austria, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Austria, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Austria, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Belgium, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Belgium, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 101: Belgium, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 102: Denmark, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 103: Denmark, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 104: Denmark, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 105: Finland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 106: Finland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 107: Finland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 108: Ireland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 109: Ireland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 110: Ireland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 111: Netherlands, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 112: Netherlands, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 113: Netherlands, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 114: Norway, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 115: Norway, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 116: Norway, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 117: Portugal, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 118: Portugal, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 119: Portugal, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 120: Sweden, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 121: Sweden, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 122: Sweden, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 123: Switzerland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 124: Switzerland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 125: Switzerland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 126: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 127: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 128: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 129: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 130: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 131: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 132: Czech Republic, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 133: Czech Republic, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 134: Czech Republic, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 135: Poland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 136: Poland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 137: Poland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 138: Romania, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 139: Romania, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 140: Romania, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 141: Ukraine, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 142: Ukraine, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 143: Ukraine, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 144: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 145: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 146: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 147: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 148: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 149: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 150: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 151: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 152: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 153: Mexico, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 154: Mexico, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 155: Mexico, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 156: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 157: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 158: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 159: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 160: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 161: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 162: Chile, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 163: Chile, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 164: Chile, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 165: Argentina, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 166: Argentina, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 167: Argentina, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 168: Colombia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 169: Colombia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 170: Colombia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 171: Peru, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 172: Peru, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 173: Peru, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 174: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 175: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 176: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 177: Saudi Arabia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 178: Saudi Arabia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 179: Saudi Arabia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 180: Israel, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 181: Israel, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 182: Israel, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 183: Iran, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 184: Iran, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 185: Iran, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 186: Turkey, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 187: Turkey, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 188: Turkey, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 189: United Arab Emirates, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 190: United Arab Emirates, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 191: United Arab Emirates, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 192: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 193: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 194: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 195: Egypt, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 196: Egypt, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 197: Egypt, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 198: Nigeria, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 199: Nigeria, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 200: Nigeria, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 201: South Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 202: South Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 203: South Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 204: Global Nucleic Acid Based Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 205: Global Nucleic Acid Based Gene Therapy Market - Company Scoring Matrix
  • Table 206: Celsion Corporation Financial Performance
  • Table 207: Wave Life Sciences Financial Performance
  • Table 208: Imugene Ltd. Financial Performance
  • Table 209: Caperna LLC Financial Performance
  • Table 210: Phylogica Limited Financial Performance
  • Table 211: Global Nucleic Acid Based Gene Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 212: Global Nucleic Acid Based Gene Therapy Market, Competitive Dashboard
  • Table 213: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 214: Global, Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 215: Global, Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 216: Global, Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Nucleic Acid Based Gene Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Nucleic Acid Based Gene Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Nucleic Acid Based Gene Therapy Market, Supply Chain Analysis
  • Figure 4: Global Nucleic Acid Based Gene Therapy Market, Major Raw Material Providers
  • Figure 5: Global Nucleic Acid Based Gene Therapy Market, Major Resource Providers
  • Figure 6: Global Nucleic Acid Based Gene Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Nucleic Acid Based Gene Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global Nucleic Acid Based Gene Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global Nucleic Acid Based Gene Therapy Market, Major Trends
  • Figure 10: Global Nucleic Acid Based Gene Therapy Market, Major End Users
  • Figure 11: Global Nucleic Acid Based Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Nucleic Acid Based Gene Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Nucleic Acid Based Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Nucleic Acid Based Gene Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Anti-Sense And Anti-Gene, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Short Inhibitory Sequences (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Gene Transfer Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Nucleoside Analogs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Ribozymes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Nucleic Acid Based Gene Therapy Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Bangladesh, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Bangladesh, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Bangladesh, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Thailand, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Thailand, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Thailand, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Vietnam, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Vietnam, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Vietnam, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Malaysia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Malaysia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Malaysia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Singapore, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Singapore, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Singapore, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Philippines, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Philippines, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Philippines, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Hong Kong, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Hong Kong, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Hong Kong, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: New Zealand, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: New Zealand, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: New Zealand, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Taiwan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Taiwan, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Taiwan, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: South East Asia , Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: South East Asia , Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: South East Asia , Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: France, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Italy, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Spain, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Austria, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Austria, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Austria, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Belgium, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Belgium, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 101: Belgium, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 102: Denmark, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 103: Denmark, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 104: Denmark, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 105: Finland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 106: Finland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 107: Finland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 108: Ireland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 109: Ireland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 110: Ireland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 111: Netherlands, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 112: Netherlands, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 113: Netherlands, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 114: Norway, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 115: Norway, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 116: Norway, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 117: Portugal, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 118: Portugal, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 119: Portugal, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 120: Sweden, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 121: Sweden, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 122: Sweden, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 123: Switzerland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 124: Switzerland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 125: Switzerland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 126: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 127: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 128: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 129: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 130: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 131: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 132: Czech Republic, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 133: Czech Republic, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 134: Czech Republic, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 135: Poland, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 136: Poland, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 137: Poland, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 138: Romania, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 139: Romania, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 140: Romania, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 141: Ukraine, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 142: Ukraine, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 143: Ukraine, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 144: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 145: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 146: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 147: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 148: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 149: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 150: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 151: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 152: Canada, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 153: Mexico, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 154: Mexico, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 155: Mexico, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 156: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 157: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 158: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 159: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 160: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 161: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 162: Chile, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 163: Chile, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 164: Chile, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 165: Argentina, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 166: Argentina, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 167: Argentina, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 168: Colombia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 169: Colombia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 170: Colombia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 171: Peru, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 172: Peru, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 173: Peru, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 174: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 175: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 176: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 177: Saudi Arabia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 178: Saudi Arabia, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 179: Saudi Arabia, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 180: Israel, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 181: Israel, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 182: Israel, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 183: Iran, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 184: Iran, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 185: Iran, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 186: Turkey, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 187: Turkey, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 188: Turkey, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 189: United Arab Emirates, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 190: United Arab Emirates, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 191: United Arab Emirates, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 192: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 193: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 194: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 195: Egypt, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 196: Egypt, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 197: Egypt, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 198: Nigeria, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 199: Nigeria, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 200: Nigeria, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 201: South Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 202: South Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 203: South Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 204: Global Nucleic Acid Based Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 205: Global Nucleic Acid Based Gene Therapy Market - Company Scoring Matrix
  • Figure 206: Celsion Corporation Financial Performance
  • Figure 207: Wave Life Sciences Financial Performance
  • Figure 208: Imugene Ltd. Financial Performance
  • Figure 209: Caperna LLC Financial Performance
  • Figure 210: Phylogica Limited Financial Performance
  • Figure 211: Global Nucleic Acid Based Gene Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 212: Global Nucleic Acid Based Gene Therapy Market, Competitive Dashboard
  • Figure 213: Global Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 214: Global, Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 215: Global, Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 216: Global, Nucleic Acid Based Gene Therapy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Frequently Asked Questions

The Nucleic Acid Based Gene Therapy market was valued at $0.88 billion in 2025, increased to $0.97 billion in 2026, and is projected to reach $1.44 billion by 2030.

The global Nucleic Acid Based Gene Therapy market is expected to grow at a CAGR of 10.4% from 2026 to 2035 to reach $1.44 billion by 2035.

Some Key Players in the Nucleic Acid Based Gene Therapy market Include, Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc. .

Major trend in this market includes: Personalized Autologous Stem Cell Therapies Driving Growth in Rare Disease Treatment . For further insights on this market. request a sample here

North America was the largest region in the nucleic acid-based gene therapy market in 2025. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts